Skip to main content

Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.

Publication ,  Journal Article
Toh, S; Baker, MA; Brown, JS; Kornegay, C; Platt, R; Mini-Sentinel Investigators,
Published in: JAMA Intern Med
May 13, 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Intern Med

DOI

EISSN

2168-6114

Publication Date

May 13, 2013

Volume

173

Issue

9

Start / End Page

817 / 819

Location

United States

Related Subject Headings

  • Varenicline
  • United States Food and Drug Administration
  • United States
  • Tobacco Use Disorder
  • Smoking Cessation
  • Sentinel Surveillance
  • Risk Factors
  • Risk Assessment
  • Quinoxalines
  • Product Surveillance, Postmarketing
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Toh, S., Baker, M. A., Brown, J. S., Kornegay, C., Platt, R., & Mini-Sentinel Investigators, . (2013). Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med, 173(9), 817–819. https://doi.org/10.1001/jamainternmed.2013.3004
Toh, Sengwee, Meghan A. Baker, Jeffrey S. Brown, Cynthia Kornegay, Richard Platt, and Richard Mini-Sentinel Investigators. “Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.JAMA Intern Med 173, no. 9 (May 13, 2013): 817–19. https://doi.org/10.1001/jamainternmed.2013.3004.
Toh S, Baker MA, Brown JS, Kornegay C, Platt R, Mini-Sentinel Investigators. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13;173(9):817–9.
Toh, Sengwee, et al. “Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.JAMA Intern Med, vol. 173, no. 9, May 2013, pp. 817–19. Pubmed, doi:10.1001/jamainternmed.2013.3004.
Toh S, Baker MA, Brown JS, Kornegay C, Platt R, Mini-Sentinel Investigators. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13;173(9):817–819.

Published In

JAMA Intern Med

DOI

EISSN

2168-6114

Publication Date

May 13, 2013

Volume

173

Issue

9

Start / End Page

817 / 819

Location

United States

Related Subject Headings

  • Varenicline
  • United States Food and Drug Administration
  • United States
  • Tobacco Use Disorder
  • Smoking Cessation
  • Sentinel Surveillance
  • Risk Factors
  • Risk Assessment
  • Quinoxalines
  • Product Surveillance, Postmarketing